Skip to main content

DXP ENTERPRISES INC

For the period ended Sep 30, 2025. Filed Nov 6, 2025.

View on SEC.gov

About this filing

A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.

Sep 30, 2025 · Filed Nov 6, 2025

DXPE$156.54+11.3%Stored close · as of Nov 9, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

ITEM 1. Financial Statements

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

AND COMPREHENSIVE INCOME

(in thousands, except per share amounts) (unaudited)

Three Months Ended September 30,Nine Months Ended September 30,
2025202420252024
Sales$513,724$472,935$1,488,975$1,331,126
Cost of sales352,465326,8251,019,638923,341
Gross profit161,259146,110469,337407,785
Selling, general and administrative expenses117,561106,502339,138301,694
Income from operations43,69839,608130,199106,091
Interest expense14,89415,71644,29846,644
Other (income) expense, net (Note 15)(648)160(2,320)(2,844)
Income before income taxes29,45223,73288,22162,291
Provision for income taxes7,8212,63122,38913,165
Net income21,63121,10165,83249,126
Preferred stock dividend23236868
Net income attributable to common shareholders$21,608$21,078$65,764$49,058
Net income$21,631$21,101$65,832$49,126
Foreign currency translation adjustments(709)3801,940(141)
Comprehensive income$20,922$21,481$67,772$48,985
Earnings per share (Note 9):
Basic$1.38$1.34$4.19$3.08
Diluted$1.31$1.27$3.98$2.93
Weighted average common shares outstanding:
Basic15,68615,75015,69315,915
Diluted16,52616,59016,53316,755

CONDENSED CONSOLIDATED BALANCE SHEETS

(in thousands, except share amounts) (unaudited)

September 30, 2025December 31, 2024
ASSETS
Current assets:
Cash$123,829$148,320
Restricted cash—91
Accounts receivable, net of allowance of $4,175 and $5,172, respectively379,328339,365
Inventories109,055103,113
Costs and estimated profits in excess of billings57,69650,735
Prepaid expenses and other current assets57,02020,250
Total current assets726,928661,874
Property and equipment, net110,95781,556
Goodwill466,710452,343
Other intangible assets, net75,41985,679
Operating lease right of use assets, net59,93646,569
Other long-term assets4,50421,473
Total assets$1,444,454$1,349,494
LIABILITIES AND EQUITY
Current liabilities:
Current maturities of debt$6,595$6,595
Trade accounts payable115,216103,728
Accrued wages and benefits47,69341,650
Customer advances15,86413,655
Billings in excess of costs and estimated profits17,06012,662
Short-term operating lease liabilities17,16314,921
Other current liabilities42,69750,773
Total current liabilities262,288243,984
Long-term debt, net of unamortized debt issuance costs and discounts619,396621,684
Long-term operating lease liabilities44,53533,159
Other long-term liabilities29,89627,879
Total long-term liabilities693,827682,722
Total liabilities956,115926,706
Commitments and Contingencies (Note 10)
Shareholders' equity:
Series A preferred stock, $1.00 par value; 1,000,000 shares authorized11
Series B preferred stock, $1.00 par value; 1,000,000 shares authorized1515
Common stock, $0.01 par value, 100,000,000 shares authorized; 20,404,367 issued and 15,677,406 outstanding at September 30, 2025 and 20,402,861 issued and 15,695,088 outstanding at December 31, 2024204204
Additional paid-in capital219,329219,511
Retained earnings455,434389,670
Accumulated other comprehensive loss(31,670)(33,610)
Treasury stock, at cost 4,726,961 and 4,707,773 shares, respectively(154,974)(153,003)
Total DXP Enterprises, Inc. equity488,339422,788
Total liabilities and equity$1,444,454$1,349,494

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands) (unaudited)

Nine Months Ended September 30,
20252024
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income$65,832$49,126
Reconciliation of net income to net cash provided by operating activities:
Depreciation7,6466,821
Amortization of intangibles and finance lease assets20,89817,564
Amortization of debt issuance costs2,9082,678
Gain on sale of property and equipment(426)—
Recovery of (provision for) credit losses74(783)
Payment of contingent consideration liability in excess of acquisition-date fair value(459)(108)
Fair value adjustment on contingent consideration932380
Restricted stock compensation expense4,2783,398
Deferred income taxes23,503(10,376)
Other non-cash items(8,142)152
Changes in operating assets and liabilities, net of effects of businesses acquired:
Accounts receivable(33,346)(12,325)
Costs and estimated profits in excess of billings(6,914)(7,392)
Inventories(1,332)1,130
Prepaid expenses and other assets(9,867)772
Trade accounts payable6,7661,323
Accrued expenses16,94711,894
Billings in excess of costs and estimated profits3,9892,410
Income taxes(36,782)3,404
Net cash provided by operating activities$56,505$70,068
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property and equipment(37,000)(15,673)
Proceeds from the sale of property and equipment2,715—
Acquisition of businesses, net of cash acquired(24,448)(149,440)
Net cash used in investing activities$(58,733)$(165,113)
CASH FLOWS FROM FINANCING ACTIVITIES:
Borrowings on asset-backed credit facility—6,000
Repayments on asset-backed credit facility—(6,000)
Principal debt payments(4,871)(4,125)
Debt issuance costs(325)—
Shares repurchased held in treasury(1,999)(28,783)
Payment for acquisition contingent consideration liability(6,874)(4,580)
Preferred stock dividends paid(68)(68)
Payment for employee taxes withheld from stock awards(4,460)(1,818)
Principal payments on finance leases(4,597)(3,010)
Net cash used in financing activities$(23,194)$(42,384)
Effect of foreign currency on cash840(691)
Net change in cash and restricted cash(24,582)(138,120)
Cash and restricted cash at beginning of period148,411173,211
Cash and restricted cash at end of period$123,829$35,091
Supplemental cash flow information (Note 14)

CONDENSED CONSOLIDATED STATEMENTS OF EQUITY

(in thousands) (unaudited)

Series A preferred stockSeries B preferred stockCommon stockPaid-in capitalRetained earningsAccum other comp lossTreasury StockTotal equity
Balance at December 31, 2024$1$15$204$219,511$389,670$(33,610)$(153,003)$422,788
Preferred dividends paid————(23)——(23)
Compensation expense for restricted stock———1,317———1,317
Tax related items for share based awards———(126)———(126)
Currency translation adjustment—————86—86
Excise tax on share repurchases——————2828
Net income————20,589——20,589
Balance at March 31, 2025$1$15$204$220,702$410,236$(33,524)$(152,975)$444,659
Preferred dividends paid————(22)——(22)
Compensation expense for restricted stock———1,483———1,483
Tax related items for share based awards———(4,203)———(4,203)
Currency translation adjustment—————2,563—2,563
Net income————23,612——23,612
Balance at June 30, 2025$1$15$204$217,982$433,826$(30,961)$(152,975)$468,092
Preferred dividends paid————(23)——(23)
Compensation expense for restricted stock———1,478———1,478
Tax related items for share based awards———(131)———(131)
Currency translation adjustment—————(709)—(709)
Repurchases of shares——————(1,999)(1,999)
Net income————21,631——21,631
Balance at September 30, 2025$1$15$204$219,329$455,434$(31,670)$(154,974)$488,339

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements

Series A preferred stockSeries B preferred stockCommon stockPaid-in capitalRetained earningsAccum other comp lossTreasury StockTotal equity
Balance at December 31, 2023$1$15$345$216,482$319,271$(31,240)$(123,995)$380,879
Preferred dividends paid————(23)——(23)
Compensation expense for restricted stock———864———864
Tax related items for share based awards———(54)———(54)
Currency translation adjustment—————(614)—(614)
Repurchases of shares——————(16,805)(16,805)
Excise tax on share repurchases——————(115)(115)
Net income————11,332——11,332
Balance at March 31, 2024$1$15$345$217,292$330,580$(31,854)$(140,915)$375,464
Preferred dividends paid————(22)——(22)
Compensation expense for restricted stock———1,212———1,212
Tax related items for share based awards———(1,701)———(1,701)
Currency translation adjustment—————93—93
Repurchases of shares——————(6,992)(6,992)
Excise tax on share repurchases——————(66)(66)
Net income————16,693——16,693
Balance at June 30, 2024$1$15$345$216,803$347,251$(31,761)$(147,973)$384,681
Preferred dividends paid————(23)——(23)
Restricted stock compensation expense———1,322———1,322
Tax related items for share based awards———(63)———(63)
Currency translation adjustment—————380—380
Repurchases of shares——————(4,985)(4,985)
Excise tax on share repurchases——————(45)(45)
Net income————21,101——21,101
Balance at September 30, 2024$1$15$345$218,062$368,329$(31,381)$(153,003)$402,368

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

NOTE 1 -THE COMPANY

DXP Enterprises, Inc. together with its subsidiaries (collectively "DXP," the "Company," "us," "we," or "our") was incorporated in Texas on July 26, 1996. DXP Enterprises, Inc. and its subsidiaries are engaged in the business of distributing maintenance, repair and operating ("MRO") products and services to a variety of end markets and business-to-business customers. Additionally, DXP provides integrated, custom pump skid packages, pump remanufacturing and manufactures branded private label pumps to energy and broad industrial customers. The Company is currently organized into three business segments: Service Centers ("SC"), Innovative Pumping Solutions ("IPS"), and Supply Chain Services ("SCS"). See Note 11 - Segment Reporting for discussion of the business segments.

NOTE 2 -SUMMARY OF SIGNIFICANT ACCOUNTING AND BUSINESS POLICIES

Basis of Presentation

The Company's financial statements are prepared in accordance with generally accepted accounting principles in the United States of America ("U.S. GAAP"). For interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X of the U.S. Securities and Exchange Commission ("SEC") not all disclosures normally required in annual consolidated financial statements prepared in accordance with U.S. GAAP are required. The unaudited condensed consolidated financial statements should be read in conjunction with our audited consolidated financial statements for the year ended December 31, 2024 that are included in our annual report on Form 10-K filed with the SEC on March 10, 2025 (“Annual Report”).

Certain reclassifications were made to the prior year’s consolidated financial statements to conform to the current year presentation. Such reclassifications did not have a material effect on our consolidated statements of operations and comprehensive income, balance sheets, cash flows or equity.

The results of operations for the three and nine months ended September 30, 2025 are not necessarily indicative of results expected for the full fiscal year. In the opinion of management, the accompanying unaudited condensed consolidated financial statements reflect all normal recurring adjustments necessary for the fair statement of the Company's financial position, results of operations and cash flows for the interim periods presented.

All intercompany accounts and transactions have been eliminated in consolidation.

NOTE 3 -RECENT ACCOUNTING PRONOUNCEMENTS

All new accounting pronouncements that have been issued but not yet effective are currently being evaluated and at this time are not expected to have a material impact on our financial position or results of operations.

Accounting Pronouncements Not Yet Adopted

In November 2024, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2024-03, Disaggregation of Income Statement Expenses (Subtopic 220-40). The ASU requires the disaggregated disclosure of specific expense categories, including purchases of inventory, employee compensation, depreciation, and amortization, within relevant income statement captions. This ASU also requires disclosure of the total amount of selling expenses along with the definition of selling expenses. The ASU is effective for annual periods beginning after December 15, 2026, and interim periods within fiscal years beginning after December 15, 2027. Adoption of this ASU can either be applied prospectively to consolidated financial statements issued for reporting periods after the effective date of this ASU or retrospectively to any or all prior periods presented in the consolidated financial statements. Early adoption is also permitted. This ASU would result in additional disclosures being included in our consolidated financial statements, once adopted. We are currently evaluating the provisions of this ASU.

In December 2023, FASB issued ASU No. 2023-09, Improvements to Income Tax Disclosures (Topic 740). The ASU requires disaggregated information about a reporting entity’s effective tax rate reconciliation as well as additional information on income taxes paid. The ASU is effective on a prospective basis for annual periods beginning after December 15, 2024. Early adoption is also permitted for annual financial statements that have not yet been issued or made available for issuance. This ASU will likely result in the required additional disclosures being included in our consolidated financial statements, once adopted. We are currently evaluating the provisions of this ASU.

NOTE 4 -FAIR VALUE OF FINANCIAL ASSETS AND LIABILITIES

Our acquisitions may include contingent consideration as part of the purchase price. The fair value of the contingent consideration is estimated as of the acquisition date based on the present value of the contingent payments to be made using a weighted probability of possible payments. The unobservable inputs used in the determination of the fair value of the contingent consideration include management's assumptions about the likelihood of payment based on the established benchmarks, discount rates, and an internal rate of return analysis. The fair value measurement includes inputs that are Level 3 inputs as they are not observable in the market. Should actual results increase or decrease as compared to the assumptions used in our analysis, the fair value of the contingent consideration obligations will increase or decrease, up to the contracted limit, as applicable. Changes in the fair value of the contingent consideration are measured each reporting period and reflected in our results of operations.

As of September 30, 2025, there was $10.6 million in other current and other long-term liabilities for contingent consideration.

The following table provides a reconciliation of the beginning and ending balances and gains or losses recognized during the nine months ended September 30, 2025 (in thousands):

Contingent Consideration
*Beginning balance at December 31, 2024$16,322
Acquisitions and settlements:
Acquisitions (Note 12)683
Settlements(7,333)
Total remeasurement adjustments:
Changes in fair value recorded in other expense (income), net932
*Ending Balance at September 30, 2025$10,604
*Amounts included in other current liabilities were $7.7 million and $8.0 million for the periods ending September 30, 2025 and December 31, 2024, respectively. Amounts included in other long-term liabilities were $2.9 million and $8.3 million for the periods ending September 30, 2025 and December 31, 2024, respectively.

Sensitivity to Changes in Significant Unobservable Inputs

The significant Level 3 unobservable inputs used in the fair value measurement of contingent consideration related to the acquisitions are annualized EBITDA forecasts developed by the Company's management and the probability of achievement of those EBITDA results. The discount rate used in the calculations was 9.3 percent. Changes in our unobservable inputs in isolation would result in a change to our fair value measurement. As of September 30, 2025, the maximum amount of contingent consideration payable under these arrangements is $11.8 million over three years.

Other financial instruments not measured at fair value on the Company's unaudited condensed consolidated balance sheets at September 30, 2025 and December 31, 2024, but which require disclosure of their fair values include: cash, restricted cash, accounts receivable, trade accounts payable and accrued expenses. The Company believes that the estimated fair value of such instruments at September 30, 2025 and December 31, 2024 approximates their carrying value as reported on the unaudited condensed consolidated balance sheets due to the relative short maturity of these instruments.

See Note 8 - Long-term Debt for fair value disclosures on our asset-backed line of credit and term loan debt under our syndicated credit agreement facilities.

NOTE 5 –INVENTORIES

Inventories are made up of equipment purchased for resale, and materials utilized in the fabrication of industrial and wastewater equipment stated at lower of cost or net realizable value, primarily determined using the weighted average cost method. The Company reviews inventory and records provisions for the difference between cost and net realizable value arising from excess and obsolete items on hand based upon the aging of the inventories, market trends, and continued demand.

The carrying values of inventories are as follows (in thousands):

September 30, 2025December 31, 2024
Finished goods$94,728$89,780
Work in process14,32713,333
Inventories$109,055$103,113

NOTE 6 –CONTRACT ASSETS AND LIABILITIES

Under our customized pump production and water and wastewater project contracts, amounts are billed as work progresses in accordance with agreed-upon contractual terms, upon various measures of performance, including achievement of certain milestones, completion of specified units, or completion of a contract. Generally, billing occurs subsequent to revenue recognition, resulting in contract assets presented as "Costs and estimated profits in excess of billings." However, we sometimes receive advances or deposits from our customers before revenue is recognized, resulting in contract liabilities that are presented as "Billings in excess of costs and estimated profits" on our unaudited condensed consolidated balance sheets.

Costs and estimated profits on uncompleted contracts and related amounts billed were as follows (in thousands):

September 30, 2025December 31, 2024
Costs incurred on uncompleted contracts$148,600$122,951
Estimated profits, thereon70,92758,373
Total costs and estimated profits on uncompleted contracts219,527181,324
Less: billings to date178,891143,251
Net$40,636$38,073

Such amounts were included in the accompanying unaudited condensed consolidated balance sheets for September 30, 2025 and December 31, 2024 under the following captions (in thousands):

September 30, 2025December 31, 2024
Costs and estimated profits in excess of billings$57,696$50,735
Billings in excess of costs and estimated profits(17,060)(12,662)
Net$40,636$38,073

During the nine months ended September 30, 2025 and 2024, $7.9 million and $5.3 million of the balances that were previously classified as contract liabilities at the beginning of the period were recognized in revenues, respectively. Contract asset and liability changes were primarily due to normal activity and timing differences between our performance and customer payments.

NOTE 7 –INCOME TAXES

The following table presents provision for income taxes (in thousands, except for effective tax rate):

Three Months Ended September 30,Nine Months Ended September 30,
2025202420252024
Income before provision for income taxes$29,452$23,732$88,221$62,291
Provision for income taxes7,8212,63122,38913,165
Effective tax rate26.6%11.1%25.4%21.1%

We are subject to income taxes in the U.S. and foreign jurisdictions. Significant judgment is required in determining our provision for income taxes and evaluating our uncertain tax positions. The effective tax rate increased primarily due to a lower tax benefit from research and development tax credits, lower tax benefit from stock compensation vested during the period, partially offset by a higher benefit for state income taxes.

While we believe that we have adequately provided for all uncertain tax positions, or tax positions where we believe it is not more-likely-than-not that the position will be sustained upon review, amounts asserted by tax authorities could be greater or less than our accrued position. Accordingly, our provisions on federal, state and foreign tax related matters to be recorded in the future may change as revised estimates are made or the underlying matters are settled or otherwise resolved with the respective tax authorities.

On July 4, 2025, the United States Congress passed the budget reconciliation bill H.R. 1, known as the One Big Beautiful Bill Act (“OBBBA”). Key provisions include the repeal of Section 174 R&D capitalization requirements, the extension of 100% bonus depreciation, restoration of the Section 163(j) interest limitation to an EBITDA basis, and the introduction of a 1% charitable contribution deduction floor. As of September 30, 2025, the immediate expensing of R&D costs under Section 174, the continuation of 100% bonus depreciation, and the restoration of the EBITDA-based Section 163(j) limitation are expected to decrease cash taxes in the short term and generate a federal net operating loss. These changes are not expected to have a material impact on the Company’s effective tax rate.

The Organization of Economic Cooperation and Development (“OECD”) continues to release additional guidance, including administrative guidance on how Pillar Two rules should be interpreted and applied by jurisdictions as they adopt Pillar Two. A number of countries have utilized the administrative guidance as a starting point for legislation that went into effect January 1, 2024. As of September 30, 2025, DXP anticipates the impact of Pillar Two to be immaterial to the Company based on current legislation that has been enacted to date.

NOTE 8 –LONG-TERM DEBT

Long-term debt consisted of the following (in thousands):

September 30, 2025December 31, 2024
ABL Revolver$—$—
Amended Senior Secured Term Loan B due October 13, 2030(1)643,005647,876
Promissory Note due November 1, 20291,0001,000
Total debt644,005648,876
Less: current maturities(6,595)(6,595)
Total long-term debt$637,410$642,281
Unamortized discount and debt issuance costs18,01420,597
Long-term debt, net of unamortized discount and debt issuance costs$619,396$621,684
(1) The fair value of the Amended Term Loan B due October 13, 2030 using level 2 input values was $647.8 million and $657.6 million as of September 30, 2025 and December 31, 2024, respectively.

Senior Secured Term Loan B:

On October 3, 2024, the Company entered into an amendment on its existing Senior Secured Term Loan B (the “Term Loan Amendment”), which provides for, among other things, an additional $105.0 million in new incremental commitments. The Term Loan Amendment refinanced the existing Senior Term Loan B and replaced it with an Amended Senior Secured Term Loan B with total borrowings of $649.5 million. The Senior Secured Term Loan B amortizes in equal quarterly installments of 0.25 percent, with the remaining balance being payable on October 13, 2030, when the facility matures.

As of September 30, 2025 there was $643.0 million outstanding under the Amended Senior Secured Term Loan B.

Interest rate

The interest rate for the Amended Senior Secured Term Loan B was 7.91 percent and 8.32 percent as of September 30, 2025 and December 31, 2024, respectively.

Facility Size Increases

The Senior Secured Term Loan B allows for incremental increases in facility size up to an aggregate of $100 million.

Prepayments

We are required to repay the Senior Secured Term Loan B with the proceeds from certain asset sales, certain debt issuances, and certain insurance proceeds. In addition, on an annual basis, we are required to repay an amount equal to 50 percent of excess cash flow, as defined in the Senior Secured Term Loan B, reducing to 25 percent if our Total Leverage Ratio is less than or equal to 3.00 to 1.00. No payment of excess cash flow is required if the Total Leverage Ratio is less than or equal to 2.50 to 1.00.

Restrictive Covenants

The Company’s primary financial covenant under the Term Loan B is a Secured Leverage Ratio. The Term Loan B Agreement requires that the Company’s Secured Leverage Ratio as of September 30, 2025 to be less than 5.50 to 1.00.

As of September 30, 2025, the Company’s Secured Leverage Ratio was 2.31 to 1.00.

ABL Revolver:

On July 1, 2025, the Company entered into an Increase Agreement (the “Increase Agreement”) to which the aggregate commitments under the Company's existing asset-based revolving credit facility (the "ABL Facility") were increased by $50 million. Following the effectiveness of the Increase Agreement, the total commitments under the ABL Facility increased from $135.0 million to $185.0 million.

On July 19, 2022, the Company entered into an Amended and Restated Loan and Security Agreement (the “ABL Credit Agreement”) that provided for a $135.0 million asset-backed revolving line of credit (the "ABL Revolver"). Subject to the conditions set forth in the ABL Credit Agreement, the ABL Revolver may be increased in increments of $10.0 million up to an aggregate of $50.0 million. The ABL Revolver matures on July 19, 2027. Interest accrues on outstanding borrowings at a rate equal to SOFR plus a margin ranging from 1.25 percent to 1.75 percent per annum, or at an alternate base rate, Canadian prime rate or Canadian base rate plus a margin ranging from 0.25 percent to 0.75 percent per annum, in each case, based upon the average daily excess availability under the ABL Revolver for the most recently completed calendar quarter. Fees payable on the unused portion of the facility range from 0.25 percent to 0.375 percent per annum. At September 30, 2025 the unused line fee was 0.375 percent and there wereno amounts outstanding under the ABL Revolver.

Guarantees

Each of our current and future wholly owned material U.S. subsidiaries and DXP Enterprises, Inc. guarantees the obligations of our borrower under the ABL Revolver. Additionally, each of our Canadian subsidiaries guarantees the obligations of our Canadian borrower subsidiaries under the ABL Revolver.

Security

Obligations under the U.S. Borrowing Base are primarily secured, subject to certain exceptions, by a first-priority secure interest in the accounts receivable, inventory and related assets of our wholly owned, material U.S. subsidiaries. The security interest in accounts receivable, inventory, and related assets of the U.S. borrower subsidiaries ranks prior to the security interest in this collateral which secures the Term Loan B. The obligations under the Canadian Borrowing Base are primarily secured, subject to certain exceptions, by a first-priority secure interest in the accounts receivable, inventory and related assets of our wholly owned, material Canadian subsidiaries and our wholly owned material U.S. subsidiaries.

Excess Availability

The borrowing availability under our credit facility was $153.4 million and $125.6 million at September 30, 2025 and December 31, 2024, respectively.

Interest rate

The interest rate for the ABL Revolver was 7.50 percent and 7.75 percent as of September 30, 2025 and December 31, 2024, respectively.

Facility Size Increases

Effective, July 1, 2025, the Company exercised its right to increase the ABL Credit Agreement by an aggregate amount of $50 million.

Financial Covenant

The Company's principal financial covenant under the ABL Credit Agreement include a Fixed Charge Coverage Ratio. The Fixed Charge Coverage Ratio under the ABL Credit Agreement is defined as the ratio for the most recently completed four-fiscal quarter period, of (a) EBITDA minus capital expenditures (excluding those financed or funded with debt (other than the ABL Loans), (ii) the portion thereof funded with the net proceeds from asset dispositions of equipment or real property which the Company is permitted to reinvest pursuant to the Term Loan and the portion thereof funded with the net proceeds of casualty insurance or condemnation awards in respect of any equipment and real estate which DXP is not required to use to prepay the ABL Loans pursuant to the Term Loan B Agreement or with the proceeds of casualty insurance or condemnation awards in respect of any other property) minus cash taxes paid (net of cash tax refunds received during such period), to (b) fixed charges. The Company is restricted from allowing its fixed charge coverage ratio to be less than 1.00 to 1.00 during a compliance period, which is triggered when the availability under the ABL Revolver falls below a threshold set forth in the ABL Credit Agreement. As of September 30, 2025, the Company's Fixed Charge Coverage Ratio was 2.18 to 1.00.

The Company was in compliance with all financial covenants as of September 30, 2025.

As of September 30, 2025, the maturities of long-term debt for the next five years and thereafter were as follows (in thousands):

Amount
2025$1,724
20266,595
20276,595
20286,595
20297,095
Thereafter615,401
Total$644,005
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.